BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 112 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,274,000 | -14.4% | 1,950,000 | 0.0% | 0.02% | -18.2% |
| Q2 2020 | $8,502,000 | +15.0% | 1,950,000 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $7,391,000 | -40.0% | 1,950,000 | 0.0% | 0.02% | -26.7% |
| Q4 2019 | $12,324,000 | +50.1% | 1,950,000 | 0.0% | 0.03% | +50.0% |
| Q3 2019 | $8,210,000 | +21.8% | 1,950,000 | +34.5% | 0.02% | +17.6% |
| Q2 2019 | $6,743,000 | +373.2% | 1,450,000 | +93.3% | 0.02% | +325.0% |
| Q1 2017 | $1,425,000 | +62.9% | 750,000 | +50.0% | 0.00% | +100.0% |
| Q4 2016 | $875,000 | -86.3% | 500,000 | -37.5% | 0.00% | -87.5% |
| Q2 2015 | $6,368,000 | -24.2% | 800,000 | 0.0% | 0.02% | -20.0% |
| Q1 2015 | $8,401,000 | -12.6% | 800,000 | 0.0% | 0.02% | -16.7% |
| Q4 2014 | $9,616,000 | -59.8% | 800,000 | -42.9% | 0.02% | -59.3% |
| Q3 2014 | $23,926,000 | -11.9% | 1,400,000 | -37.8% | 0.06% | -15.7% |
| Q2 2014 | $27,158,000 | +17.0% | 2,250,000 | -18.2% | 0.07% | +11.1% |
| Q1 2014 | $23,210,000 | +71.3% | 2,750,000 | +19.6% | 0.06% | +75.0% |
| Q4 2013 | $13,547,000 | +8.5% | 2,300,000 | 0.0% | 0.04% | 0.0% |
| Q3 2013 | $12,489,000 | +33.7% | 2,300,000 | 0.0% | 0.04% | +24.1% |
| Q2 2013 | $9,338,000 | -3.6% | 2,300,000 | 0.0% | 0.03% | -9.4% |
| Q1 2013 | $9,683,000 | – | 2,300,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Capital Management | 1,000 | $3,000 | 0.00% |
| Close Asset Management Ltd | 7,500 | $23,000 | 0.00% |
| IFP Advisors, Inc | 250 | $1,000 | 0.00% |